PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
PART 05: Overview: Conjunctivitis
- Types of conjunctivitis
- Signs and symptoms
- Diagnosis
PART 06: Pipeline analysis
- AC-170
- AGN-229666
- DEXTENZA
- SUN-1334H
- Auriclosene
- EBI-005
- FST-100
- SPL7013
- OPX-1
- AzaSite Xtra (ISV-405)
- GD134
PART 07: Market landscape
- Market overview
- Market size and forecast
- Conjunctivitis medication market in the US
- Bacterial conjunctivitis medication market in the US
- Viral conjunctivitis medication market in the US
- Allergic conjunctivitis medication market in the US
- Five forces analysis
PART 08: Market segmentation based on condition type
- Bacterial conjunctivitis medication
- Viral conjunctivitis medication
- Allergic conjunctivitis medication
- Global bacterial conjunctivitis medication market
- Global viral conjunctivitis medication market
- Global allergic conjunctivitis medication market
PART 09: Geographical segmentation
- Geographical segmentation of global conjunctivitis medication market
- Conjunctivitis medication market in the Americas
- Conjunctivitis medication market in EMEA
- Conjunctivitis medication market in APAC
PART 10: Market drivers
- Increased exposure to chemicals and pollutants
- Rising awareness of condition
- Exploring specific treatment for viral conjunctivitis
- Tentative approval of pipeline candidates
PART 11: Impact of drivers
PART 12: Market challenges
- Patent expiry of medication
- Contentment with existing therapies
- Adverse effects and limited efficacy of medication
PART 13: Impact of drivers and challenges
PART 14: Market trends
- Strategic alliances and M&A
- Use of combination therapies
- Increased R&D
PART 15: Vendor landscape
- Competitive scenario
- Market share analysis 2014
- Other prominent vendors
PART 16: Key vendor analysis
- Akorn
- Alcon
- Allergan
- Bausch & Lomb
PART 17: Appendix
- List of abbreviations
PART 18: Explore Technavio

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Causes of conjunctivitis
Exhibit 03: Types of bacterial conjunctivitis
Exhibit 04: Types of viral conjunctivitis
Exhibit 05: Types of allergic conjunctivitis
Exhibit 06: Signs and symptoms of common forms of conjunctivitis
Exhibit 07: Medication used for treatment of conjunctivitis
Exhibit 08: Global conjunctivitis market: Pipeline portfolio
Exhibit 09: Global conjunctivitis market 2014-2019 ($ billions)
Exhibit 10: Conjunctivitis market in the US 2014-2019 ($ billions)
Exhibit 11: Percentage shares of conjunctivitis medication market in the US and outside the US
Exhibit 12: Segmentation of conjunctivitis medication market in US based on condition type 2014
Exhibit 13: Bacterial conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 14: Viral conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 15: Allergic conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 16: Conjunctivitis market in US: YoY growth and revenue based on condition type 2014-2019
Exhibit 17: Five forces analysis
Exhibit 18: Segmentation of global conjunctivitis medication market based on condition type
Exhibit 19: Segmentation of global conjunctivitis medication market based on condition type 2014
Exhibit 20: Global bacterial conjunctivitis medication market 2014-2019 ($ billions)
Exhibit 21: Global viral conjunctivitis medication market 2014-2019 ($ millions)
Exhibit 22: Global allergic conjunctivitis medication market 2014-2019 ($ billions)
Exhibit 23: Global conjunctivitis medication market: YoY growth and revenue based on condition type 2014-2019
Exhibit 24: Geographical segmentation of global conjunctivitis medication market 2014
Exhibit 25: Conjunctivitis medication market in the Americas 2014-2019 ($ billions)
Exhibit 26: Conjunctivitis medication market in EMEA 2014-2019 ($ millions)
Exhibit 27: Conjunctivitis medication market in APAC 2014-2019 ($ millions)
Exhibit 28: YoY growth and revenue of global conjunctivitis medication market by region 2014-2019
Exhibit 29: Impact of drivers
Exhibit 30: Impact of drivers and challenges
Exhibit 31: YoY growth and revenue generated from sales of ophthalmic therapeutics 2011-2013 ($ millions)
Exhibit 32: Akorn: Key takeaways
Exhibit 33: YoY growth and revenue generated from sales of ophthalmic products 2011-2014 ($ billions)
Exhibit 34: Percentage share of divisions of Alcon based on revenue 2014
Exhibit 35: Alcon: Key takeaways
Exhibit 36: Allergan: Key takeaways
Exhibit 37: Allergan: Business segmentation 2014 by revenue
Exhibit 38: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 39: Allergan: Geographical segmentation by revenue 2014
Exhibit 40: Bausch & Lomb: Product categories